FDA Issues New Draft Guidances On Cancer Clinical Trial Eligibility Criteria
Understand the latest FDA guidance on cancer clinical trials with summary and content from Marjorie Zettler, Ph.D., MPH.
Source: clinicalleader.com
Karnofsky Performance Status News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Karnofsky Performance Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Karnofsky Performance Status Today - Breaking & Trending Today
Tai Chi Improves Perceived Cognitive Impairment in Lung Cancer Survivors
A randomized clinical trial compared tai chi, aerobic exercise, and self-managed exercises to measure improvement in perceived cognitive impairment among NSCLC survivors. Tai chi offered significant improvement in perceived cognitive impairment for survivors of NSCLC, compared with aerobic and self-managed exercises.
Source: oncologynurseadvisor.com
Vebreltinib Receives NMPA Approval in China for MET Fusion+ Glioma
Vebreltinib has received approval from China’s NMPA in pretreated IDH-mutant, PTPRZ1-MET fusion–positive astrocytoma or glioblastoma.
Source: onclive.com
FDA Issues New Draft Guidances On Cancer Clinical Trial Eligibility Criteria
Understand the latest FDA guidance on cancer clinical trials with summary and content from Marjorie Zettler, Ph.D., MPH.
Source: lifescienceleader.com
Actinium s Four Presentations at ASH Highlight the Positive Outcomes for Iomab-B and Actimab-A in Patients with Relapsed or Refractory Acute Myeloid Leukemia
NEW YORK - Actinium Pharmaceuticals, Inc. , a leader in the development of targeted radiotherapies, today highlighted four presentations at the 65th Annual American Society of Hematology Annual...
Source: marketscreener.com